QQ客服 官方微博 反馈留言

	Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition
	Deng Yu[1]; Li Fulun[2]; He Pinglin[3]; Yang Yafei[4]; Yang Jin[5]; Zhang Yamei[6]; Liu Junying[7]; Tong Yongping[8]; Li Qingfeng[9]; Mei Xian[10]
刊名	Molecular carcinogenesis
	2018
卷号	57页码:807-814
关键词	ATM DNA damage response Triptolide chemosensitization
ISSN号	1098-2744
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2181761
专题	上海大学
作者单位	1.Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Affiliated with Shanghai University of Traditional Chinese Medicine, Shanghai, P.R China. 2.Department of Urology, Chengdu University Hospital, Chengdu, P.R China. 3.Central Lab, Chengdu University Hospital, Chengdu, P.R China. 4.Department of Pathology, Shifang People's Hospital, Shifang, P.R China. 5.Department of Neurosurgery, Shifang People's Hospital, Shifang, P.R China. 6.School of Pharmacology and Bioengineering, Chengdu University, Chengdu, P.R China.
推荐引用方式 GB/T 7714	Deng Yu[1],Li Fulun[2],He Pinglin[3],et al. Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition[J]. Molecular carcinogenesis,2018,57:807-814.
APA	Deng Yu[1].,Li Fulun[2].,He Pinglin[3].,Yang Yafei[4].,Yang Jin[5].,...&Zhao Qi[12].(2018).Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition.Molecular carcinogenesis,57,807-814.
MLA	Deng Yu[1],et al."Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition".Molecular carcinogenesis 57(2018):807-814.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。